↓ Skip to main content

Dove Medical Press

Treatment and management of myelofibrosis in the era of JAK inhibitors [Corrigendum]

Overview of attention for article published in Biologics: Targets & Therapy, October 2013
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
1 Mendeley
Title
Treatment and management of myelofibrosis in the era of JAK inhibitors [Corrigendum]
Published in
Biologics: Targets & Therapy, October 2013
DOI 10.2147/btt.s54093
Pubmed ID
Authors

Claire Harrison, Deepti Deepti Radia, Clodagh Keohane

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 October 2013.
All research outputs
#22,759,452
of 25,374,647 outputs
Outputs from Biologics: Targets & Therapy
#245
of 284 outputs
Outputs of similar age
#194,931
of 219,852 outputs
Outputs of similar age from Biologics: Targets & Therapy
#2
of 4 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 284 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 219,852 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.